Lurking dangers behind overuse of lamivudine to treat non-HIV hepatitis B patients in Africa

dc.contributor.authorKangbai, J
dc.date.accessioned2026-10-19T22:23:12Z
dc.date.issued2013
dc.identifier.citationKangbai, J. (2013). Lurking dangers behind overuse of lamivudine to treat non-HIV hepatitis B patients in Africa. Annals of Medical and Health Sciences Research, 3(2), 296. https://doi.org/10.4103/2141-9248.113689
dc.identifier.doi10.4103/2141-9248.113689
dc.identifier.urihttps://doi.org/10.4103/2141-9248.113689
dc.identifier.urihttps://dspace.njala.edu.sl/handle/20.500.144402/1297
dc.language.isoen
dc.publisherMedknow
dc.relation.ispartofAnnals of Medical and Health Sciences Research
dc.rightsCC BY-NC-SA
dc.subjectlamivudine
dc.titleLurking dangers behind overuse of lamivudine to treat non-HIV hepatitis B patients in Africa
dc.typeArticle

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description: